Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners

Latham & Watkins represented Spectrum Pharmaceuticals in the deal. Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Procept BioRobotics’ $163.9 Million Initial Public Offering

Latham & Watkins represented PROCEPT in the transaction. PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology,...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here